Startseite/Aktien/OMER

OMER

USD

Omeros Corporation Common Stock

$6.730-0.330 (-4.674%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$7.060

Hoch

$7.240

Tief

$6.710

Volumen

1.29M

Unternehmensfundamentaldaten

Marktkapitalisierung

458.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

3.30M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $2.95Aktuell $6.730Hoch $13.6

Ähnliche Nachrichten

15. Okt. 2025 · 12:34

Reuters

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and kidney disorders, they said on Wednesday.

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

15. Okt. 2025 · 12:30

GlobeNewswire

Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rare Disease portfolioOmeros is eligible to receive 340 million US dollars in upfront and near-term